Certified by Founder
Lodge
Biorithm
start up
Singapore
- Singapore
- 19/12/2023
- Series A
- $3,500,000
By leading a new standard of maternity care, Biorithm aims to end preventable pregnancy complications & stillbirth through predictive and precision medicine.
Forging new frontiers in women's health and pregnancy care to improve outcomes globally, we have developed cutting-edge analytic software together with medical-grade wearables for accurate monitoring of a wide range of pregnancy data.
Founded by doctors & engineers, Biorithm is a medical technology company, spun off from Nanyang Technological University Singapore (NTU).
- Industry Medical Device
- Website https://www.bio-rithm.com/
- LinkedIn https://www.linkedin.com/company/biorithm/about/
Related People
Amrish NairFounder
Singapore -
Singapore
Signal processing engineer with a focus on sparse sampling and biomedical applications. Experience with academia and interdisciplinary research with clinicians.
Elly | $8,000,000 | (Feb 26, 2026)
Sinergy Flow | $8,273,230 | (Feb 26, 2026)
Abram Scientific | $11,750,000 | (Feb 26, 2026)
Allica Bank | $155,000,000 | (Feb 26, 2026)
Quill Meetings | $6,500,000 | (Feb 26, 2026)
Avisi Technologies | $10,700,000 | (Feb 26, 2026)
TBD | $3,000,000 | (Feb 26, 2026)
NationGraph | $18,000,000 | (Feb 26, 2026)
Cicada | $13,500,000 | (Feb 26, 2026)
Centauri Therapeutics Limited | $8,107,170 | (Feb 25, 2026)
Koah | $20,500,000 | (Feb 25, 2026)
Nimble | $47,000,000 | (Feb 25, 2026)